adamantane has been researched along with Death, Sudden, Cardiac in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatt, DL; Braunwald, E; Cavallari, I; Im, K; Leiter, LA; McGuire, DK; Mosenzon, O; Raz, I; Scirica, BM; Steg, PG | 1 |
| Aquilante, CL; Bilker, WB; Bloomgarden, ZT; Brensinger, CM; Dawwas, GK; Deo, R; Dhopeshwarkar, N; Flory, JH; Hennessy, S; Kimmel, SE; Leonard, CE; Soprano, SE | 1 |
2 other study(ies) available for adamantane and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Causes and Risk Factors for Death in Diabetes: A Competing-Risk Analysis From the SAVOR-TIMI 53 Trial.
Topics: Adamantane; Aged; Biomarkers; Cause of Death; Coronary Artery Disease; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Heart Disease Risk Factors; Humans; Male; Mortality; Risk Assessment | 2021 |
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population-Based Cohort Studies.
Topics: Adamantane; Administrative Claims, Healthcare; Aged; Arrhythmias, Cardiac; Cohort Studies; Databases, Factual; Death, Sudden, Cardiac; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Kaplan-Meier Estimate; Linagliptin; Male; Middle Aged; Proportional Hazards Models; Sitagliptin Phosphate | 2022 |